Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Jun 6;24(1):293.
doi: 10.1186/s12872-024-03904-0.

Left atrial appendage closure in a patient previously implanted with an interatrial shunt device: a case report

Affiliations
Case Reports

Left atrial appendage closure in a patient previously implanted with an interatrial shunt device: a case report

Dawei Lin et al. BMC Cardiovasc Disord. .

Abstract

Patients with previous interatrial shunt device (IASD) implantation may face greater challenges during future left atrial interventional procedures. Herein, we report the first case of left atrial appendage closure (LAAC) in a patient with previous IASD implantation. The patient successfully underwent LAAC using the LAmbre device without complications.

Keywords: FreeFlow®; Interatrial shunt device (IASD); LAmbre device; Left atrial appendage closure (LAAC).

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The FreeFlow® device has a “double elliptical discs, one hole” structure weaved by Nickel-titanium alloy wires, and a 5 mm diameter iatrogenic shunt. (A) Front view. (B) Side view
Fig. 2
Fig. 2
TEE examination showed a “Cauliflower” kind LAA morphology (A, B, C, and D)
Fig. 3
Fig. 3
Fluoroscopy images showed the procedure of LAAC. (A) MPA catheter passed atrial septal through the ISAD. (B) Contrast was injected into LAA. (C) A 30–36 mm LAmbre occluder anchored appropriately. (D) The external disc of the occluder was opened. (E) Occluder was released after confirmation of proper positioning

Similar articles

References

    1. Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, et al. Left atrial appendage Closure Versus Direct oral anticoagulants in high-risk patients with Atrial Fibrillation. J Am Coll Cardiol. 2020;75(25):3122–35. doi: 10.1016/j.jacc.2020.04.067. - DOI - PubMed
    1. Al-Abcha A, Saleh Y, Elsayed M, Elshafie A, Herzallah K, Baloch ZQ, et al. Left atrial appendage Closure Versus oral anticoagulation in Non-valvular Atrial Fibrillation: a systematic review and Meta-analysis. Cardiovasc Revasc Med. 2022;36:18–24. doi: 10.1016/j.carrev.2021.04.019. - DOI - PubMed
    1. Xipell M, Flores-Umanzor E, Ojeda R, Arias M, Cepas-Guillen PL, Regueiro A, et al. Percutaneous left atrial appendage closure, a safe alternative to anticoagulation for patients with nonvalvular atrial fibrillation and end-stage renal disease on hemodialysis: a single center experience. Artif Organs. 2020;44(5):513–21. doi: 10.1111/aor.13603. - DOI - PubMed
    1. Kar S, Doshi SK, Sadhu A, Horton R, Osorio J, Ellis C, et al. Primary outcome evaluation of a Next-Generation Left Atrial Appendage Closure device: results from the PINNACLE FLX Trial. Circulation. 2021;143(18):1754–62. doi: 10.1161/CIRCULATIONAHA.120.050117. - DOI - PubMed
    1. Du H, Bi K, Xu L, Chen F, Xiong W, Wang Y. Analysis of risk factors for thrombosis of the left atrium/left atrial appendage in patients with non-valvular atrial fibrillation. Cardiovasc J Afr. 2021;32(3):116–22. - PMC - PubMed

Publication types

MeSH terms